nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—ABCB11—Vincristine—muscle cancer	0.354	0.37	CbGbCtD
Clofazimine—ABCB11—Doxorubicin—muscle cancer	0.221	0.231	CbGbCtD
Clofazimine—ABCB1—Dactinomycin—muscle cancer	0.0986	0.103	CbGbCtD
Clofazimine—ABCB1—Vincristine—muscle cancer	0.0607	0.0634	CbGbCtD
Clofazimine—ABCB1—Etoposide—muscle cancer	0.0556	0.0581	CbGbCtD
Clofazimine—ABCB1—Doxorubicin—muscle cancer	0.0379	0.0396	CbGbCtD
Clofazimine—ABCB1—Methotrexate—muscle cancer	0.0368	0.0384	CbGbCtD
Clofazimine—CYP3A4—Vincristine—muscle cancer	0.0364	0.038	CbGbCtD
Clofazimine—CYP3A4—Etoposide—muscle cancer	0.0333	0.0348	CbGbCtD
Clofazimine—CYP3A4—Doxorubicin—muscle cancer	0.0227	0.0237	CbGbCtD
Clofazimine—Hepatomegaly—Dactinomycin—muscle cancer	0.00173	0.0407	CcSEcCtD
Clofazimine—Intestinal obstruction—Vincristine—muscle cancer	0.0016	0.0377	CcSEcCtD
Clofazimine—Enteritis—Methotrexate—muscle cancer	0.00155	0.0365	CcSEcCtD
Clofazimine—Thromboembolism—Doxorubicin—muscle cancer	0.00144	0.034	CcSEcCtD
Clofazimine—Bone pain—Vincristine—muscle cancer	0.00114	0.0269	CcSEcCtD
Clofazimine—Skin discolouration—Etoposide—muscle cancer	0.000979	0.0231	CcSEcCtD
Clofazimine—Embolism venous—Doxorubicin—muscle cancer	0.000909	0.0214	CcSEcCtD
Clofazimine—Embolism—Methotrexate—muscle cancer	0.000825	0.0194	CcSEcCtD
Clofazimine—Embolism—Doxorubicin—muscle cancer	0.000714	0.0168	CcSEcCtD
Clofazimine—Neuralgia—Doxorubicin—muscle cancer	0.00066	0.0156	CcSEcCtD
Clofazimine—Hepatomegaly—Doxorubicin—muscle cancer	0.000648	0.0153	CcSEcCtD
Clofazimine—Photosensitivity reaction—Vincristine—muscle cancer	0.000625	0.0147	CcSEcCtD
Clofazimine—Weight decreased—Vincristine—muscle cancer	0.000619	0.0146	CcSEcCtD
Clofazimine—Hepatitis—Dactinomycin—muscle cancer	0.000613	0.0145	CcSEcCtD
Clofazimine—Depression—Vincristine—muscle cancer	0.000609	0.0144	CcSEcCtD
Clofazimine—Skin discolouration—Methotrexate—muscle cancer	0.000586	0.0138	CcSEcCtD
Clofazimine—Cystitis noninfective—Methotrexate—muscle cancer	0.000517	0.0122	CcSEcCtD
Clofazimine—Cystitis—Methotrexate—muscle cancer	0.000511	0.0121	CcSEcCtD
Clofazimine—Skin discolouration—Doxorubicin—muscle cancer	0.000508	0.012	CcSEcCtD
Clofazimine—Anaemia—Dactinomycin—muscle cancer	0.000494	0.0116	CcSEcCtD
Clofazimine—Jaundice—Etoposide—muscle cancer	0.000482	0.0114	CcSEcCtD
Clofazimine—Bladder pain—Methotrexate—muscle cancer	0.000479	0.0113	CcSEcCtD
Clofazimine—Bone pain—Doxorubicin—muscle cancer	0.000479	0.0113	CcSEcCtD
Clofazimine—Lymphadenopathy—Methotrexate—muscle cancer	0.000451	0.0106	CcSEcCtD
Clofazimine—Cystitis noninfective—Doxorubicin—muscle cancer	0.000448	0.0106	CcSEcCtD
Clofazimine—Cystitis—Doxorubicin—muscle cancer	0.000443	0.0104	CcSEcCtD
Clofazimine—Anaemia—Vincristine—muscle cancer	0.000441	0.0104	CcSEcCtD
Clofazimine—Oedema—Dactinomycin—muscle cancer	0.000436	0.0103	CcSEcCtD
Clofazimine—Anorexia—Dactinomycin—muscle cancer	0.000415	0.00979	CcSEcCtD
Clofazimine—Bladder pain—Doxorubicin—muscle cancer	0.000415	0.00977	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000407	0.0096	CcSEcCtD
Clofazimine—Lymphadenopathy—Doxorubicin—muscle cancer	0.00039	0.0092	CcSEcCtD
Clofazimine—Oedema—Vincristine—muscle cancer	0.000389	0.00918	CcSEcCtD
Clofazimine—Decreased appetite—Dactinomycin—muscle cancer	0.000379	0.00893	CcSEcCtD
Clofazimine—Fatigue—Dactinomycin—muscle cancer	0.000376	0.00886	CcSEcCtD
Clofazimine—Anorexia—Vincristine—muscle cancer	0.000371	0.00875	CcSEcCtD
Clofazimine—Anaemia—Etoposide—muscle cancer	0.000357	0.00842	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000353	0.00832	CcSEcCtD
Clofazimine—Body temperature increased—Dactinomycin—muscle cancer	0.000345	0.00812	CcSEcCtD
Clofazimine—Decreased appetite—Vincristine—muscle cancer	0.000338	0.00798	CcSEcCtD
Clofazimine—Fatigue—Vincristine—muscle cancer	0.000336	0.00791	CcSEcCtD
Clofazimine—Constipation—Vincristine—muscle cancer	0.000333	0.00785	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000333	0.00785	CcSEcCtD
Clofazimine—Eosinophilia—Methotrexate—muscle cancer	0.000329	0.00775	CcSEcCtD
Clofazimine—Asthenia—Dactinomycin—muscle cancer	0.000313	0.00737	CcSEcCtD
Clofazimine—Body temperature increased—Vincristine—muscle cancer	0.000308	0.00726	CcSEcCtD
Clofazimine—Abdominal pain upper—Doxorubicin—muscle cancer	0.000304	0.00717	CcSEcCtD
Clofazimine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000303	0.00715	CcSEcCtD
Clofazimine—Hypokalaemia—Doxorubicin—muscle cancer	0.000303	0.00714	CcSEcCtD
Clofazimine—Anorexia—Etoposide—muscle cancer	0.000301	0.00709	CcSEcCtD
Clofazimine—Diarrhoea—Dactinomycin—muscle cancer	0.000298	0.00703	CcSEcCtD
Clofazimine—Drowsiness—Methotrexate—muscle cancer	0.000296	0.00698	CcSEcCtD
Clofazimine—Depression—Methotrexate—muscle cancer	0.000295	0.00696	CcSEcCtD
Clofazimine—Eosinophilia—Doxorubicin—muscle cancer	0.000285	0.00671	CcSEcCtD
Clofazimine—Somnolence—Etoposide—muscle cancer	0.00028	0.00661	CcSEcCtD
Clofazimine—Asthenia—Vincristine—muscle cancer	0.000279	0.00659	CcSEcCtD
Clofazimine—Vomiting—Dactinomycin—muscle cancer	0.000277	0.00653	CcSEcCtD
Clofazimine—Rash—Dactinomycin—muscle cancer	0.000275	0.00648	CcSEcCtD
Clofazimine—Decreased appetite—Etoposide—muscle cancer	0.000274	0.00646	CcSEcCtD
Clofazimine—Fatigue—Etoposide—muscle cancer	0.000272	0.00641	CcSEcCtD
Clofazimine—Constipation—Etoposide—muscle cancer	0.00027	0.00636	CcSEcCtD
Clofazimine—Diarrhoea—Vincristine—muscle cancer	0.000266	0.00628	CcSEcCtD
Clofazimine—Hepatitis—Methotrexate—muscle cancer	0.000266	0.00627	CcSEcCtD
Clofazimine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000263	0.00619	CcSEcCtD
Clofazimine—Weight decreased—Doxorubicin—muscle cancer	0.00026	0.00614	CcSEcCtD
Clofazimine—Hyperglycaemia—Doxorubicin—muscle cancer	0.00026	0.00612	CcSEcCtD
Clofazimine—Nausea—Dactinomycin—muscle cancer	0.000259	0.0061	CcSEcCtD
Clofazimine—Dizziness—Vincristine—muscle cancer	0.000257	0.00607	CcSEcCtD
Clofazimine—Drowsiness—Doxorubicin—muscle cancer	0.000257	0.00605	CcSEcCtD
Clofazimine—Visual impairment—Methotrexate—muscle cancer	0.000256	0.00604	CcSEcCtD
Clofazimine—Jaundice—Doxorubicin—muscle cancer	0.00025	0.00589	CcSEcCtD
Clofazimine—Body temperature increased—Etoposide—muscle cancer	0.000249	0.00588	CcSEcCtD
Clofazimine—Vomiting—Vincristine—muscle cancer	0.000248	0.00584	CcSEcCtD
Clofazimine—Rash—Vincristine—muscle cancer	0.000246	0.00579	CcSEcCtD
Clofazimine—Dermatitis—Vincristine—muscle cancer	0.000245	0.00578	CcSEcCtD
Clofazimine—Headache—Vincristine—muscle cancer	0.000244	0.00575	CcSEcCtD
Clofazimine—Nausea—Vincristine—muscle cancer	0.000231	0.00545	CcSEcCtD
Clofazimine—Hepatitis—Doxorubicin—muscle cancer	0.00023	0.00543	CcSEcCtD
Clofazimine—Asthenia—Etoposide—muscle cancer	0.000226	0.00533	CcSEcCtD
Clofazimine—Pruritus—Etoposide—muscle cancer	0.000223	0.00526	CcSEcCtD
Clofazimine—Visual impairment—Doxorubicin—muscle cancer	0.000222	0.00523	CcSEcCtD
Clofazimine—Diarrhoea—Etoposide—muscle cancer	0.000216	0.00509	CcSEcCtD
Clofazimine—Anaemia—Methotrexate—muscle cancer	0.000214	0.00504	CcSEcCtD
Clofazimine—Dizziness—Etoposide—muscle cancer	0.000209	0.00492	CcSEcCtD
Clofazimine—Vomiting—Etoposide—muscle cancer	0.000201	0.00473	CcSEcCtD
Clofazimine—Rash—Etoposide—muscle cancer	0.000199	0.00469	CcSEcCtD
Clofazimine—Dermatitis—Etoposide—muscle cancer	0.000199	0.00468	CcSEcCtD
Clofazimine—Headache—Etoposide—muscle cancer	0.000198	0.00466	CcSEcCtD
Clofazimine—Nausea—Etoposide—muscle cancer	0.000187	0.00442	CcSEcCtD
Clofazimine—Anaemia—Doxorubicin—muscle cancer	0.000185	0.00437	CcSEcCtD
Clofazimine—Anorexia—Methotrexate—muscle cancer	0.00018	0.00425	CcSEcCtD
Clofazimine—Somnolence—Methotrexate—muscle cancer	0.000168	0.00396	CcSEcCtD
Clofazimine—Decreased appetite—Methotrexate—muscle cancer	0.000164	0.00387	CcSEcCtD
Clofazimine—Oedema—Doxorubicin—muscle cancer	0.000164	0.00386	CcSEcCtD
Clofazimine—Fatigue—Methotrexate—muscle cancer	0.000163	0.00384	CcSEcCtD
Clofazimine—Anorexia—Doxorubicin—muscle cancer	0.000156	0.00368	CcSEcCtD
Clofazimine—Body temperature increased—Methotrexate—muscle cancer	0.000149	0.00352	CcSEcCtD
Clofazimine—Somnolence—Doxorubicin—muscle cancer	0.000145	0.00343	CcSEcCtD
Clofazimine—Decreased appetite—Doxorubicin—muscle cancer	0.000142	0.00335	CcSEcCtD
Clofazimine—Fatigue—Doxorubicin—muscle cancer	0.000141	0.00333	CcSEcCtD
Clofazimine—Constipation—Doxorubicin—muscle cancer	0.00014	0.0033	CcSEcCtD
Clofazimine—Asthenia—Methotrexate—muscle cancer	0.000136	0.0032	CcSEcCtD
Clofazimine—Pruritus—Methotrexate—muscle cancer	0.000134	0.00315	CcSEcCtD
Clofazimine—Body temperature increased—Doxorubicin—muscle cancer	0.000129	0.00305	CcSEcCtD
Clofazimine—Diarrhoea—Methotrexate—muscle cancer	0.000129	0.00305	CcSEcCtD
Clofazimine—Dizziness—Methotrexate—muscle cancer	0.000125	0.00295	CcSEcCtD
Clofazimine—Vomiting—Methotrexate—muscle cancer	0.00012	0.00283	CcSEcCtD
Clofazimine—Rash—Methotrexate—muscle cancer	0.000119	0.00281	CcSEcCtD
Clofazimine—Dermatitis—Methotrexate—muscle cancer	0.000119	0.00281	CcSEcCtD
Clofazimine—Headache—Methotrexate—muscle cancer	0.000118	0.00279	CcSEcCtD
Clofazimine—Asthenia—Doxorubicin—muscle cancer	0.000117	0.00277	CcSEcCtD
Clofazimine—Pruritus—Doxorubicin—muscle cancer	0.000116	0.00273	CcSEcCtD
Clofazimine—Nausea—Methotrexate—muscle cancer	0.000112	0.00265	CcSEcCtD
Clofazimine—Diarrhoea—Doxorubicin—muscle cancer	0.000112	0.00264	CcSEcCtD
Clofazimine—Dizziness—Doxorubicin—muscle cancer	0.000108	0.00255	CcSEcCtD
Clofazimine—Vomiting—Doxorubicin—muscle cancer	0.000104	0.00245	CcSEcCtD
Clofazimine—Rash—Doxorubicin—muscle cancer	0.000103	0.00243	CcSEcCtD
Clofazimine—Dermatitis—Doxorubicin—muscle cancer	0.000103	0.00243	CcSEcCtD
Clofazimine—Headache—Doxorubicin—muscle cancer	0.000102	0.00242	CcSEcCtD
Clofazimine—Nausea—Doxorubicin—muscle cancer	9.72e-05	0.00229	CcSEcCtD
